
    
      In this prospective randomized non-inferiority study we aim to determine the utility of
      axillary ultrasound (AUS) as a pre-operative staging modality for patients with clinically
      node-negative invasive breast cancer with the hope that it will be a minimally invasive
      replacement for SLNB.
    
  